Search Results 1111-1120 of 18721 for hepatitis

1. Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis - Mayo Clinic

   - STEP 1: Participants must not be seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Subjects with resolved ...

2. Untitled

   And we prevent liver cancer, well the best way of preventing it is by trying to prevent liver disease from happening. So, I mentioned earlier Hepatitis B,.

3. A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer - Mayo Clinic

   ... hepatitis B or hepatitis C infection. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

4. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma - Mayo Clinic

   hepatitis B surface antigen or hepatitis C antibody - No history of any other condition that may require the initiation of anti-tumor necrosis factor alpha ...

5. Sorafenib (oral route) - Side effects & dosage - Mayo Clinic

   These could be symptoms of a serious liver condition called hepatitis. If you plan to have children, talk with your doctor before using this medicine. Some ...

6. A Study Of The Pan-KRAS Inhibitor LY4066434 In Participants With KRAS Mutant Solid Tumors - Mayo Clinic

   * Have known active hepatitis B virus (HBV), hepatitis C virus (HCV) and untreated HIV infection * Have other active malignancy unless in remission with ...

7. Videos - Membrane Trafficking in Disease - Mayo Clinic Research

   ... Hepatitis B Infection · Tumor Cell Growth and Migration · Publications; Media Media. Images · Videos · Contact. Videos. All videos are copyrighted by Mayo ...

8. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

   Has a known history of hepatitis B (defined as hepatitis ... Note: no testing for hepatitis B and hepatitis C is required unless mandated by local health ...

9. Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007) - Mayo Clinic

   - Has an active infection requiring systemic therapy. - Has a known history of human immunodeficiency virus (HIV), Hepatitis B or/and. Hepatitis C virus.

10. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    Subjects with hepatitis B core antibody positive who are surface antigen negative or who are hepatitis ... Those who are hepatitis B surface antigen positive or ...